Gentian Diagnostics AS - Asset Resilience Ratio

Latest as of December 2025: 40.97%

Gentian Diagnostics AS (GENT) has an Asset Resilience Ratio of 40.97% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Nkr105.93 Million

≈ $11.15 Million USD Cash + Short-term Investments

Total Assets

Nkr258.54 Million

≈ $27.21 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Gentian Diagnostics AS's Asset Resilience Ratio has changed over time. Check Gentian Diagnostics AS strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Gentian Diagnostics AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Gentian Diagnostics AS market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Nkr105.93 Million	40.97%
Short-term Investments	Nkr0.00	0%
Total Liquid Assets	Nkr105.93 Million	40.97%

Asset Resilience Insights

Very High Liquidity: Gentian Diagnostics AS maintains exceptional liquid asset reserves at 40.97% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Gentian Diagnostics AS Industry Peers by Asset Resilience Ratio

Compare Gentian Diagnostics AS's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shanghai MicroPort EV MedTech Co. Ltd. A SHG:688351	Medical Devices	49.23%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Vitrolife AB ST:VITR	Medical Devices	7.27%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%
Imricor Medical Systems Inc AU:IMR	Medical Devices	46.50%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Annual Asset Resilience Ratio for Gentian Diagnostics AS (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Gentian Diagnostics AS.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	36.90%	Nkr84.74 Million ≈ $8.92 Million	Nkr229.66 Million ≈ $24.17 Million	+35.79pp
2023-12-31	1.11%	Nkr2.01 Million ≈ $211.62K	Nkr181.04 Million ≈ $19.05 Million	+0.01pp
2022-12-31	1.11%	Nkr2.08 Million ≈ $218.46K	Nkr187.79 Million ≈ $19.76 Million	-53.16pp
2021-12-31	54.27%	Nkr114.94 Million ≈ $12.09 Million	Nkr211.79 Million ≈ $22.29 Million	-12.88pp
2020-12-31	67.15%	Nkr157.99 Million ≈ $16.62 Million	Nkr235.26 Million ≈ $24.76 Million	-8.22pp
2019-12-31	75.37%	Nkr171.24 Million ≈ $18.02 Million	Nkr227.18 Million ≈ $23.91 Million	-1.49pp
2018-12-31	76.87%	Nkr198.31 Million ≈ $20.87 Million	Nkr257.98 Million ≈ $27.15 Million	+6.21pp
2017-12-31	70.65%	Nkr145.00 Million ≈ $15.26 Million	Nkr205.23 Million ≈ $21.60 Million	+10.40pp
2016-12-31	60.25%	Nkr74.09 Million ≈ $7.80 Million	Nkr122.96 Million ≈ $12.94 Million	--

pp = percentage points

About Gentian Diagnostics AS

OL:GENT Norway Medical Devices

Market Cap

$66.21 Million

Nkr629.23 Million NOK

Market Cap Rank

#20822 Global

#189 in Norway

Share Price

Nkr40.80

Change (1 day)

+2.77%

52-Week Range

Nkr34.60 - Nkr59.00

All Time High

Nkr86.00